Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

46 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
N-3 fatty acid supplementation to routine statin treatment inhibits platelet function, decreases patients' daytime blood pressure, and improves inflammatory status.
Doenyas-Barak K, Berman S, Abu-Hamad R, Golik A, Rahimi-Levene N, Efrati S. Doenyas-Barak K, et al. Eur J Clin Pharmacol. 2012 Aug;68(8):1139-46. doi: 10.1007/s00228-012-1235-4. Epub 2012 Feb 25. Eur J Clin Pharmacol. 2012. PMID: 22367427 Clinical Trial.
Benign familial microcytic thrombocytosis with autosomal dominant transmission.
Cohen N, Almoznino-Sarafian D, Weissgarten J, Alon I, Zaidenstein R, Dishi V, Rahimi-Levene N, Fried K, Modai D, Golik A. Cohen N, et al. Clin Genet. 1997 Jul;52(1):47-50. doi: 10.1111/j.1399-0004.1997.tb02513.x. Clin Genet. 1997. PMID: 9272712
Rebound thymic enlargement on CT in adults.
Yarom N, Zissin R, Apter S, Hertz M, Rahimi-Levene N, Gayer G. Yarom N, et al. Int J Clin Pract. 2007 Apr;61(4):562-8. doi: 10.1111/j.1742-1241.2006.00950.x. Epub 2007 Jan 29. Int J Clin Pract. 2007. PMID: 17263694
Lower hemoglobin transfusion trigger is associated with higher mortality in patients hospitalized with pneumonia.
Rahimi-Levene N, Koren-Michowitz M, Zeidenstein R, Peer V, Golik A, Ziv-Baran T. Rahimi-Levene N, et al. Medicine (Baltimore). 2018 Mar;97(12):e0192. doi: 10.1097/MD.0000000000010192. Medicine (Baltimore). 2018. PMID: 29561440 Free PMC article.
Outcomes of second-line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials.
Joffe E, Goldschmidt N, Bairey O, Fineman R, Ruchlemer R, Rahimi-Levene N, Shvidel L, Greenbaum U, Aviv A, Tadmor T, Braester A, Arad A, Polliack A, Herishanu Y; Israeli CLL Study Group. Joffe E, et al. Eur J Haematol. 2018 Sep;101(3):399-406. doi: 10.1111/ejh.13129. Epub 2018 Aug 3. Eur J Haematol. 2018. PMID: 29949186
Protein Z levels and central retinal vein or artery occlusion.
Koren-Michowitz M, Eting E, Rahimi-Levene N, Garach-Jehoshua O, Volcheck Y, Kornberg A. Koren-Michowitz M, et al. Eur J Haematol. 2005 Nov;75(5):401-5. doi: 10.1111/j.1600-0609.2005.00529.x. Eur J Haematol. 2005. PMID: 16191090
Factor VII deficiency in a patient with retinal arteriolar tortuosity syndrome.
Zadok D, Levi Y, Zehavi H, Rahimi-Levene N, Nemet P, Kornberg A. Zadok D, et al. Eye (Lond). 2000 Oct;14 Pt 5:721-3. doi: 10.1038/eye.2000.191. Eye (Lond). 2000. PMID: 11116692
Conventional dose fludarabine-based regimens are effective but have excessive toxicity in elderly patients with refractory chronic lymphocytic leukemia.
Shvidel L, Shtalrid M, Bairey O, Rahimi-Levene N, Lugassy G, Shpilberg O, Polliack A, Berrebi A; Israeli Study Group on CLL. Shvidel L, et al. Leuk Lymphoma. 2003 Nov;44(11):1947-50. doi: 10.1080/1042819031000110991. Leuk Lymphoma. 2003. PMID: 14738148
Survival trends among 1,325 patients with chronic lymphocytic leukemia seen over the past 40 years in Israel.
Shvidel L, Braester A, Bairey O, Rahimi-Levene N, Klepfish A, Herishanu Y, Shtalrid M, Polliack A, Berrebi A; Israeli CLL Study Group. Shvidel L, et al. Am J Hematol. 2011 Dec;86(12):985-92. doi: 10.1002/ajh.22160. Epub 2011 Sep 14. Am J Hematol. 2011. PMID: 21919037
Cell surface expression of CD25 antigen (surface IL-2 receptor α-chain) is not a prognostic marker in chronic lymphocytic leukemia: results of a retrospective study of 281 patients.
Shvidel L, Braester A, Bairey O, Rahimi-Levene N, Herishanu Y, Tadmor T, Klepfish A, Ruchlemer R, Shtalrid M, Berrebi A, Polliack A; Israeli CLL Study Group. Shvidel L, et al. Ann Hematol. 2012 Oct;91(10):1597-602. doi: 10.1007/s00277-012-1492-4. Epub 2012 May 24. Ann Hematol. 2012. PMID: 22623161
46 results
Jump to page